LHYY
Lego-compatible Miltenyi Biotec CliniMACS Prodigy Model
Lego-compatible Miltenyi Biotec CliniMACS Prodigy Model
Click here to submit your custom design & vector files.
Lego-compatible Miltenyi Biotec CliniMACS Prodigy Model – Scientific Display Gift
The CliniMACS Prodigy platform operates through a closed-system magnetic cell separation (MACS) architecture, integrating automated fluidics and centrifugation for ex-vivo immune cell isolation and genetic modification. This technology underpins GMP-compliant CAR-T therapy manufacturing and allogeneic stem cell transplantation in clinical hematology. The brick model faithfully reproduces the system's fluidics cartridge and magnetic separation chamber for laboratory presentations.
Customized product. Please contact us for a specific bulk quote.
Key Features:
• Detailed Lego-style replica of the CliniMACS Prodigy magnetic separation chamber and automated fluidics module.
• Fully compatible with standard LEGO bricks for seamless assembly and corporate showcases.
• Ideal promotional centerpiece for cell therapy companies, GMP biotech facilities, and immuno-oncology exhibitions.
Technical Specifications:
• Material: ABS Plastic (injection-molded, precise build).
• Compatibility: Compatible with LEGO brick systems.
• Display Grade: High-resolution scientific model optimized for desktop presentation.
Frequently Asked Questions (FAQ) for Corporate B2B Buyers:
Q: Can this Miltenyi Biotec CliniMACS Prodigy model be customized with our own corporate branding or logo?
A: Yes, LHYY GLOBAL provides bespoke enterprise logo printing and custom color-matching options for all premium brick models. Standard bulk customization orders start at a minimum order quantity (MOQ) of 1,000 sets.
Q: Is this product suitable as a premium trade show swag for international cell therapy and bioprocessing conferences?
A: Absolutely. This interactive model is structurally optimized for marketing teams and exhibitors seeking high-engagement, educational corporate gifts to feature at ISCT conferences, GMP pharma expos, and immuno-oncology congresses.
Share
